IDH mutation impairs histone demethylation and results in a block to cell differentiation

C Lu, PS Ward, GS Kapoor, D Rohle, S Turcan… - Nature, 2012 - nature.com
Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in
gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel …

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

L Dang, DW White, S Gross, BD Bennett, MA Bittinger… - Nature, 2009 - nature.com
Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature
of a major subset of primary human brain cancers. These mutations occur at a single amino …

IDH1 (R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

M Sasaki, CB Knobbe, JC Munger, EF Lind, D Brenner… - Nature, 2012 - nature.com
Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently
found in human glioblastomas and cytogenetically normal acute myeloid leukaemias (AML) …

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells

D Rohle, J Popovici-Muller, N Palaskas, S Turcan… - Science, 2013 - science.org
The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing
the altered metabolism of cancer cells for cancer therapy. One potential drug target is …

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

F Wang, J Travins, B DeLaBarre, V Penard-Lacronique… - Science, 2013 - science.org
A number of human cancers harbor somatic point mutations in the genes encoding isocitrate
dehydrogenases 1 and 2 (IDH1 and IDH2). These mutations alter residues in the enzyme …

(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

JA Losman, RE Looper, P Koivunen, S Lee… - Science, 2013 - science.org
Mutations in IDH1 and IDH2, the genes coding for isocitrate dehydrogenases 1 and 2, are
common in several human cancers, including leukemias, and result in overproduction of the …

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation

P Koivunen, S Lee, CG Duncan, G Lopez, G Lu… - Nature, 2012 - nature.com
The identification of succinate dehydrogenase (SDH), fumarate hydratase (FH) and
isocitrate dehydrogenase (IDH) mutations in human cancers has rekindled the idea that …

Rapid conversion of mutant IDH1 from driver to passenger in a model of human gliomagenesis

TCA Johannessen, J Mukherjee, P Viswanath… - Molecular Cancer …, 2016 - AACR
Missense mutations in the active site of isocitrate dehydrogenase 1 (IDH1) biologically and
diagnostically distinguish low-grade gliomas and secondary glioblastomas from primary …

IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism

JL Izquierdo-Garcia, P Viswanath, P Eriksson, L Cai… - Cancer research, 2015 - AACR
Abstract Mutant isocitrate dehydrogenase 1 (IDH1) catalyzes the production of 2-
hydroxyglutarate but also elicits additional metabolic changes. Levels of both glutamate and …

Identification of additional IDH mutations associated with oncometabolite R (−)-2-hydroxyglutarate production

PS Ward, JR Cross, C Lu, O Weigert, O Abel-Wahab… - Oncogene, 2012 - nature.com
Mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) or its mitochondrial homolog IDH2
can lead to R (−)-2-hydroxyglutarate (2HG) production. To date, mutations in three active site …